Review
Copyright ©The Author(s) 2016.
World J Gastroenterol. Aug 28, 2016; 22(32): 7289-7300
Published online Aug 28, 2016. doi: 10.3748/wjg.v22.i32.7289
Table 2 Prospective trials on transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis
GroupNo. of patientsTreatmentsChild-Pugh ASurvival
Luo et al[81]164 (84 vs 80)TACE vs ControlNot known1-yr survival 30.9% vs 9.2%
Niu et al[82]150 (115 vs 35)TACE vs Control88 vs 21Median survival 8.67 mo vs 14 mo
Kim et al[83]110 (49 vs 61)TACE vs TACI30 vs 22Median survival 14.9 mo vs 4.4 mo
Peng et al[25]603 (402 vs 201)TACE vs Resection389 vs 197Median survival 42 mo vs 14.1 mo